268 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
INCY Incyte Corporation $67.04 $14.25B N/A
Article Searches
Should You Make a Bet on the Healthcare Stocks? http://www.zacks.com/stock/news/256768/should-you-make-a-bet-on-the-healthcare-stocks?cid=CS-ZC-FT-256768 Apr 18, 2017 - The healthcare industry is much more than Obamacare and drug prices as many companies are using new technologies to create breakthroughs in medicine.
Zacks.com featured highlights: PTC, Covanta Holding, Live Nation Entertainment, Incyte and Vertex Pharmaceuticals http://www.zacks.com/stock/news/256600/zackscom-featured-highlights-ptc-covanta-holding-live-nation-entertainment-incyte-and-vertex-pharmaceuticals?cid=CS-ZC-FT-256600 Apr 18, 2017 - Zacks.com featured highlights: PTC, Covanta Holding, Live Nation Entertainment, Incyte and Vertex Pharmaceuticals
What Happened in the Stock Market Today https://www.fool.com/investing/2017/04/17/what-happened-in-the-stock-market-today.aspx?source=iedfolrf0000001 Apr 18, 2017 - Drugmakers get denied, Chipotle continues gains, and earnings season gets under way. Investors have remained optimistic ahead of what could be a tumultuous week.
Why Snyder's-Lance, Incyte, and Tenet Healthcare Slumped Today https://www.fool.com/investing/2017/04/17/why-snyders-lance-incyte-and-tenet-healthcare-slum.aspx?source=iedfolrf0000001 Apr 17, 2017 - Despite a climbing market, these stocks fell. Find out why.
Why Incyte Corporation Stock Is Plunging Today https://www.fool.com/investing/2017/04/17/why-incyte-corporation-stock-is-plunging-today.aspx?source=iedfolrf0000001 Apr 17, 2017 - Shares of Incyte and Eli Lilly are reeling following the FDA's rejection of their once-daily rheumatoid arthritis pill.
Lilly and Incyte's Loss Is AbbVie and Regeneron's Gain https://www.fool.com/investing/2017/04/17/lilly-and-incytes-loss-is-abbvie-and-regenerons-ga.aspx?source=iedfolrf0000001 Apr 17, 2017 - The FDA has rejected Eli Lilly and Incyte's application for approval of a potential blockbuster rheumatoid arthritis drug.
5 Toxic Stocks to Shun or Play Short Right Now http://www.zacks.com/stock/news/256498/5-toxic-stocks-to-shun-or-play-short-right-now?cid=CS-ZC-FT-256498 Apr 17, 2017 - Just like picking up stocks with strong growth potential, pinpointing toxic stocks and abandoning them at the right time is the key to protect your portfolio from big losses or make profits by short selling them.
Eli Lilly's Rheumatoid Arthritis Drug Gets CRL in the U.S. http://www.zacks.com/stock/news/256531/eli-lillys-rheumatoid-arthritis-drug-gets-crl-in-the-us?cid=CS-ZC-FT-256531 Apr 17, 2017 - Eli Lilly and Company (LLY) and its partner Incyte Corporation (INCY) recently announced that they have received a Complete Response Letter (CRL) from the FDA regarding the new drug application (NDA) for baricitinib.
FDA Rejects Eli Lilly and Incyte Drug https://www.wsj.com/articles/fda-rejects-eli-lilly-and-incyte-rheumatoid-arthritis-drug-1492183825?mod=pls_whats_news_us_business_f Apr 14, 2017 - Eli Lilly and Incyte said the U.S. Food and Drug Administration didn’t approve their new drug application for a rheumatoid arthritis treatment that some analysts estimate could generate more than $2 billion in annual sales.
Surprise FDA Rejection Will Sting This Biotech https://www.wsj.com/articles/surprise-fda-rejection-will-sting-this-biotech-1492185721?mod=rss_markets_main Apr 14, 2017 - A Lilly-Incyte rheumatoid arthritis drug won’t come to market any time soon after the FDA’s surprise rejection of the treatment.

Pages: 1...192021222324252627

<<<Page 24>